Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Why start-ups can become mega companies in the pharma sector

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech …


How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech…


Belgium vs Germany in the Life Sciences start-up championship

Germany is one of the leading industrial nations in the world and has 8x more inhabitants than Belgium. However, when it comes to investments in e…

POPULAR TAGS

Better decision making with VIGOR

Written by DS on in the category news with the tags , , .


The VIGOR Unit, a new spin-off of the University of Ghent, will help business leaders and policy makers take effective decisions on the basis of scientific insights and data. The focus of the founders, behavioral scientists Cédric Velghe and prof. Frederick Anseel, is on people management. Their advice relies on existing scientific data and their own tailored field research. In addition, they have developed new management tools, including psychological tests and apps.

Make data easy to interpret
Too much information and too little time often prevents managers from collecting in-depth knowledge before making important decisions. Moreover, the reliability of available information varies widely, or can be very technical. The VIGOR Unit specializes in quickly and systematically analyzing scientific publications and data.

Do what works
With its evidence-based consultancy, the VIGOR Unit wants to help businesses and governments to identify the best solutions. Understanding what works and what does not, halts senseless investments. Well-documented decisions can help to inform and convince stakeholders.

Objective assessment
The VIGOR Unit feels that sound advice alone is not enough. Managers are looking for a tool to map the innovation potential of their workforce. They want an objective test, not a self-assessment form. The VIGOR Unit responds to the upcoming evidence-based approach, as we know it in medicine. "Managers too often rely on their gut feeling, management hypes, myths or gurus. The VIGOR Unit wants to point them to what really works,” says Prof. Anseel.

(Source: UGent)

Read more about: , , .

RELATED ARTICLES
Why start-ups can become mega companies in the pharma sector

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech …


How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech…


Belgium vs Germany in the Life Sciences start-up championship

Germany is one of the leading industrial nations in the world and has 8x more inhabitants than Belgium. However, when it comes to investments in e…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK KU Leuven Turnstone Janssen Itera Life Science UGent XpandInnovation Flanders.bio Biowin V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.